IT1132168B - Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo - Google Patents

Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo

Info

Publication number
IT1132168B
IT1132168B IT23219/80A IT2321980A IT1132168B IT 1132168 B IT1132168 B IT 1132168B IT 23219/80 A IT23219/80 A IT 23219/80A IT 2321980 A IT2321980 A IT 2321980A IT 1132168 B IT1132168 B IT 1132168B
Authority
IT
Italy
Prior art keywords
active component
immunotherapeutic agent
cancer including
including lipopolysaccharide
lipopolysaccharide
Prior art date
Application number
IT23219/80A
Other languages
English (en)
Italian (it)
Other versions
IT8023219A0 (it
Inventor
Chisato Maruyama
Original Assignee
Chisato Maruyama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisato Maruyama filed Critical Chisato Maruyama
Publication of IT8023219A0 publication Critical patent/IT8023219A0/it
Application granted granted Critical
Publication of IT1132168B publication Critical patent/IT1132168B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT23219/80A 1979-07-04 1980-07-03 Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo IT1132168B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8468179A JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent

Publications (2)

Publication Number Publication Date
IT8023219A0 IT8023219A0 (it) 1980-07-03
IT1132168B true IT1132168B (it) 1986-06-25

Family

ID=13837428

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23219/80A IT1132168B (it) 1979-07-04 1980-07-03 Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo

Country Status (8)

Country Link
US (2) US4329452A (enExample)
JP (1) JPS568320A (enExample)
CA (1) CA1132047A (enExample)
CH (1) CH650799A5 (enExample)
ES (1) ES493061A0 (enExample)
FR (1) FR2484258A1 (enExample)
IT (1) IT1132168B (enExample)
SU (1) SU1232124A3 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718619A (en) * 1980-07-10 1982-01-30 Chisato Maruyama Tumor immunotherapy agent containing lipopolysaccharide as active principle
JPS59161320A (ja) * 1983-03-04 1984-09-12 Maruyama Chisato リポ多糖体およびその製造法
US4612304A (en) * 1985-06-11 1986-09-16 Ss Pharmaceutical Co., Ltd. Antitumor formulation containing lipopolysaccharide with trehalose derivatives
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
EP0295749A1 (en) * 1987-06-15 1988-12-21 Duphar International Research B.V Sulpholipopolysaccharides as stimulators of the non-specific defence mechanism
US4798369A (en) * 1987-11-03 1989-01-17 The Firestone Tire & Rubber Company Ultrasonic air spring system
US5853737A (en) * 1992-12-10 1998-12-29 Brigham And Women's Hospital Method for inducing a CD1-restricted immune response
US6238676B1 (en) * 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
US5712123A (en) * 1994-10-07 1998-01-27 Board Of Trustees Of The University Of Illinois Mixture having antitumor activities
WO1998056941A1 (en) * 1995-12-12 1998-12-17 Tai Ho Chung Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof
US5869645A (en) * 1997-10-15 1999-02-09 Board Of Trustees Of The University Of Illinois Method for isolating high molecular weight antineoplastic glycans using urea
NZ505538A (en) * 2000-07-03 2004-12-24 Malaghan Inst Of Medical Res A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
PL1765391T3 (pl) * 2004-06-07 2013-08-30 Qu Biologics Inc Kompozycje bakteryjne do leczenia nowotworów
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20070161546A1 (en) * 2005-12-15 2007-07-12 Colm King Methods and compositions for treatment of cancer
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
JP2015157763A (ja) * 2012-05-28 2015-09-03 エヌエーアイ株式会社 認知症の治療剤及び予防剤
EP3125763A4 (en) 2014-03-31 2017-12-13 University of Utah Research Foundation Fluid analysis device and associated systems and methods
CA3254723A1 (en) 2014-05-02 2025-04-15 Qu Biologics Inc ANTIMICROBIAL IMMUNOMODULATION
EP4226939A4 (en) * 2020-10-09 2024-11-13 Zeria Pharmaceutical Co., Ltd. NEW USE OF A MYCOBACTERIUM TUBERCULOSIS EXTRACT

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
NL7308450A (enExample) * 1972-06-20 1973-12-27
FR2227862A1 (en) * 1973-05-04 1974-11-29 Anvar Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
JPS5132794A (en) * 1974-06-20 1976-03-19 Anvar Koshuyokoirusu oyobi ajubantokatsuseiojusuru maikobakuteriumufurakushonnoseiseiho

Also Published As

Publication number Publication date
CH650799A5 (de) 1985-08-15
ES8105783A1 (es) 1981-06-16
US4329452A (en) 1982-05-11
JPS568320A (en) 1981-01-28
JPS6256843B2 (enExample) 1987-11-27
IT8023219A0 (it) 1980-07-03
CA1132047A (en) 1982-09-21
US4394502A (en) 1983-07-19
FR2484258A1 (fr) 1981-12-18
ES493061A0 (es) 1981-06-16
SU1232124A3 (ru) 1986-05-15
FR2484258B1 (enExample) 1984-11-30

Similar Documents

Publication Publication Date Title
IT1132168B (it) Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo
IT8067262A0 (it) Agente anti ipercolesterolemico eprocedimento per la sua preparazione
IT8048066A0 (it) Agente carcinostatico ed immunosti molante contenente lisofosfolipide e fosfolipide e procedimento per prepararlo
DK483680A (da) Triazolforbindelser
IT1072719B (it) Tenditore per stecche chirurgiche di compressione
FR2345155A1 (fr) Composition veterinaire
TR19661A (tr) Guemues katalizatoerlerin performasinin islahina mahsus usul
IT8067302A0 (it) Agente antitumorale
ES489705A0 (es) Un dosimetro mejorado
IT7925699A0 (it) Composizioni fotografiche di sbianca, e metodi per trattamento fotografico.
FR2320749A1 (fr) Composition veterinaire
BR8000934A (pt) Agente dessulfurnate para injecao
IT8048403A0 (it) Complesso multiconduttore schermato
DE3069512D1 (de) Z-bar guide apparatus
MX148583A (es) Procedimiento mejorado para la preparacion de un compuesto de organoestano
FR2471028B1 (fr) Blindage anti-neutrons
IT1130783B (it) Procedimento per la preparazione di un agente per la gelificazione di fluoroelastomeri
NL170230C (nl) Applicator voor inwendige bestraling.
IT1129952B (it) Apparecchiatura di sviluppo per diazotipia
MX149264A (es) Procedimiento mejorado para la preparacion de un compuesto de organoestano
IT1118225B (it) Procedimento per l'ottenimento di steroidi poliossidrilati,lisergolo ed alcaloidi ergolici
FI803732L (fi) 2-amino-etanol-derivat foerfarande foer deras framstaellning saodana foereningar innehaollande farmaceutiska preparat och dessas anvaendning
BE852562A (fr) Composition veterinaire
DE3067045D1 (de) Shielding door
IT7926344A0 (it) Procedimento per la fabbricazione di casse di saracinesche.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730